|
|
|
Insider
Information: |
Pops Richard F |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
1,301,687 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$38,585,989 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,301,687 |
|
|
Total
Value |
$38,585,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-03-13 |
29,512 |
2005-11-23 |
0 |
Premium* |
|
Alkermes Plc |
ALKS |
Director and CEO, Alke... |
2024-02-08 |
1,179,675 |
2011-09-16 |
0 |
Premium* |
|
Epizyme, Inc. |
EPZM |
Director |
2013-05-30 |
60,000 |
|
0 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
Director |
2019-01-25 |
32,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
257 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2016-11-22 |
4 |
AS |
$58.43 |
$1,759,936 |
D/D |
(30,000) |
608,962 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2016-11-22 |
4 |
OE |
$14.38 |
$431,400 |
D/D |
30,000 |
638,962 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2016-11-29 |
4 |
OE |
$14.38 |
$431,400 |
D/D |
30,000 |
638,962 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2016-11-29 |
4 |
AS |
$56.93 |
$1,709,469 |
D/D |
(30,000) |
608,962 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
618,962 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-02-26 |
4 |
D |
$52.98 |
$249,271 |
D/D |
(4,705) |
614,257 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-03-01 |
4 |
D |
$59.71 |
$491,652 |
D/D |
(8,234) |
623,523 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
631,757 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
30,000 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,000 |
636,523 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-03-03 |
4 |
D |
$60.97 |
$372,953 |
D/D |
(6,117) |
630,406 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2017-05-03 |
4 |
OE |
$3.40 |
$51,000 |
D/D |
15,000 |
30,454 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2017-05-03 |
4 |
D |
$53.37 |
$50,808 |
D/D |
(952) |
29,512 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-10 |
4 |
AS |
$57.12 |
$1,432,244 |
D/D |
(25,000) |
630,406 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-10 |
4 |
OE |
$15.95 |
$398,750 |
D/D |
25,000 |
655,406 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-17 |
4 |
AS |
$57.23 |
$2,909,439 |
D/D |
(50,000) |
630,406 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-17 |
4 |
OE |
$15.95 |
$797,500 |
D/D |
50,000 |
680,406 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-24 |
4 |
OE |
$15.95 |
$398,750 |
D/D |
25,000 |
655,406 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-24 |
4 |
AS |
$57.42 |
$1,435,535 |
D/D |
(25,000) |
630,406 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,750 |
644,156 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-28 |
4 |
D |
$57.70 |
$373,319 |
D/D |
(6,470) |
637,686 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-11-02 |
4 |
AS |
$48.87 |
$2,443,410 |
D/D |
(50,000) |
637,686 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-11-02 |
4 |
OE |
$14.13 |
$706,500 |
D/D |
50,000 |
687,686 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
646,436 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2018-02-17 |
4 |
D |
$67.26 |
$173,598 |
D/D |
(2,581) |
643,855 |
0 |
- |
|
257 Records found
|
|
Page 6 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|